CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $162,000 | +38.5% | 20,978 | +18.8% | 0.02% | -5.3% |
Q3 2020 | $117,000 | +25.8% | 17,660 | +57.6% | 0.02% | +35.7% |
Q2 2020 | $93,000 | -47.5% | 11,208 | -53.3% | 0.01% | -54.8% |
Q3 2019 | $177,000 | -63.7% | 23,998 | +39.7% | 0.03% | -57.5% |
Q1 2018 | $488,000 | -30.2% | 17,178 | -55.4% | 0.07% | -35.4% |
Q3 2017 | $699,000 | +239.3% | 38,485 | +221.9% | 0.11% | +135.4% |
Q1 2017 | $206,000 | – | 11,956 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |